Arbutus Biopharma Corp
ABUSUS売上高
$14M
百万USD
営業利益
$-38M
百万USD
純利益
$-34M
百万USD
ROE
-43.7%
最新FY
EPS
$-0.17
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $2M | $-16M | $-0.21 |
| FY2021 | Q2 | $2M | $-19M | $-0.23 |
| FY2021 | Q3 | $3M | $-19M | $-0.24 |
| FY2021 | FY | $11M | $-76M | $-0.83 |
| FY2022 | Q1 | $13M | $-16M | $-0.11 |
| FY2022 | Q2 | $14M | $-14M | $-0.10 |
| FY2022 | Q3 | $6M | $-18M | $-0.12 |
| FY2022 | FY | $39M | $-69M | $-0.46 |
| FY2023 | Q1 | $7M | $-16M | $-0.10 |
| FY2023 | Q2 | $5M | $-17M | $-0.10 |
| FY2023 | Q3 | $5M | $-20M | $-0.12 |
| FY2023 | FY | $18M | $-73M | $-0.44 |
| FY2024 | Q1 | $2M | $-18M | $-0.10 |
| FY2024 | Q2 | $2M | $-20M | $-0.11 |
| FY2024 | Q3 | $1M | $-20M | $-0.10 |
| FY2024 | FY | $6M | $-70M | $-0.38 |
| FY2025 | Q1 | $2M | $-25M | $-0.13 |
| FY2025 | Q2 | $11M | $3M | $0.01 |
| FY2025 | Q3 | $1M | $-8M | $-0.04 |
| FY2025 | FY | $14M | $-34M | $-0.17 |
| FY2026 | Q1 | $179M | $170M | $0.87 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | $1M | $11M | $6M | $6M | $7M | $11M | $39M | $18M | $6M | $14M |
| 営業利益 | $-492M | $-111M | $-90M | $-144M | $-58M | $-74M | $-65M | $-78M | $-76M | $-38M |
| 純利益 | $-384M | $-84M | $-57M | $-154M | $-64M | $-76M | $-69M | $-73M | $-70M | $-34M |
| 総資産 | $276M | $237M | $228M | $106M | $137M | $204M | $195M | $144M | $132M | $95M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $203M | $182M | $200M | $73M | $102M | $169M | $137M | $106M | $97M | $77M |
| 営業CF | $-58M | $-49M | $-68M | $-71M | $-51M | $-68M | $-35M | $-86M | $-65M | $-40M |
| EPS | $-7.24 | $-1.56 | $-1.21 | - | - | $-0.83 | $-0.46 | $-0.44 | $-0.38 | $-0.17 |
| BPS | $3.69 | $3.31 | $3.57 | $1.06 | $1.07 | $1.14 | $0.84 | $0.59 | $0.51 | $0.39 |
| ROE | -189.2% | -46.3% | -28.5% | -211.3% | -62.5% | -45.0% | -50.8% | -68.7% | -71.8% | -43.7% |